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ABSTRACT
Stroke is a frequent complication in patients with cancer occurring in nearly 15% of the cases. However
cerebrovascular disease as the first presentation of malignancy has rarely been reported.
We report two such cases who were admitted with acute stroke but were later on found to be having malignancy.
Routine workup was unrewarding in both patients. Both patients developed pulmonary embolism as well during
hospital stay suggesting hypercoagulable state as likely etiology. Reaching to the final diagnosis was an arduous
journey but can help guide other clinicians facing similar cases. Non Hodgkins B cell lymphoma and Carcinoma Gall
bladder were the final diagnosis in our patients. Therefore, we recommend workup for malignancy if no likely cause is
found on routine extensive workup before labelling stroke as cryptogenic stroke. Ultrasound abdomen was particularly
rewarding in our patients.
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INTRODUCTION
Stroke is a frequent complication in patients with
cancer occurring in nearly 15% of the cases. However
cerebrovascular disease as the first presentation of
malignancy has rarely been reported1.
We hereby report two of such cases where final
diagnosis was actually a malignancy but presented with
acute stroke and where we did routine extensive
workup for the etiology of stroke but was unrewarding.
CASE 1
83 years old female was admitted with history of left
sided visual field loss. She had risk factors of stroke in
form of hypertension, hypercholestrolaemia. She also
had Polymyalgia rheumatica and was on steroids.
On examination she was conscious alert with normal
vital signs. Neurological examination was all normal
except for right homonymous hamianopia.
Her investigations showed anaemia with Haemoglobin
of 8 with MCV 68. Her ESR was raised to 124 and CRP
was 259.8. Her CT brain scan confirmed a left occipital
infarct as shown in Figure 1.
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Figure 1.CTscan brain showing left occipital infarct.
Her anaemia was investigated. Her OGD was normal.
Her colonoscopy revealed angiodysplasia of colon,
argon plasma coagulation was done on caecum.
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Her echocardiogram showed mild pulmonary
hypertension and moderate to severe Aortic stenosis.
Her liver function tests showed deranged ALT of 181
which was initially attributed to Statins use. An
ultrasound abdomen was done which showed
heterogenous Hypoechoic round lesion at splenic hilum
measuring 2.5cm. It was the deranged LFTs which led
us to do ultrasound abdomen and led us to underlying
diagnosis.
She kept on spiking high grade intermittent fever for
which all relevant investigations were done including
septic screen, blood cultures which showed no growth,
serum immunoglobulins, serum electrophoresis, serum
autoantibodies and serum complement levels which
were normal.
CT abdomen showed solid mass in spleen with
extensive lymphedenopathy in the upper abdomen and
Lymphoma was suspected.
She also developed shortness of breath and hypoxia
during hospital stay, CTPA was done and showed
Segmental Pulmonary embolus within a branch of right
upper lobe artery.

CASE 2

Figure 2.MRI brain DWI sequence showing bilateral
infarcts.
All the workup for recurrent stroke including
Anticardiolipin antibodies IgG and IgM, Thrombophilia
and vasculitic screen was negative.24 hours and 5 days
ECG
monitoring
was
normal.
Transthoracic
Echocardiogram was normal. Bubble contrast
echocardiogram showed PFO.

A 62 years old lady with no previous comorbids except
for DVT leg for which she was on Rivaroxaban presented
to us with left arm weakness and facial droop was
diagnosed as having right lacunar stroke. After few
months she was readmitted with multiple episodes of
aphasia, one episode rendering her completely aphasic.

Ultrasound abdomen was done during the course of
hospital stay which showed a mass lesion involving the
fundus of the gallbladder and the adjacent liver. It also
showed small hypoechoic lesions in the adjacent liver.
Carcinoma of the gallbladder with metastases was
suspected.

MRI brain confirmed new stroke and showed areas of
restricted diffusion bilateraly in both anterior circulations
and posterior circulation as shown in figure 2.

CT abdomen and pelvis confirmed large mass of mixed
density in the gallbladder fossa with a thick enhancing
rim and another 2 cm well-defined low density lesion in
the liver.. Possibility was of gallbladder malignancy, liver
lesion was suspicious for a metastatic deposit.

She was started on therapeutic dose of Dalteparin CT
guided lymph node biopsy confirmed High grade B cell
Lymphoma.

She was Started on Therapeutic Dose Dalteparin. PEG
tube inserted
While on Dalteparin therapeutic dose developed
extensive left femoral vein DVT extending into left illiac
vein upto illiac bifurcation. IVC filter was placed.
She also developed acute shortness of breath during
hospital stay, CTPA confirmed Pulmonary embolism in
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broad laboratory assessment of hypercoagulability
including d-dimer levels in all patients with
cancer+stroke3.

form of segmental pulmonary emboli within right lower
lobe and Lingula and left lower lobe.
Gall bladder biopsy was taken and GB malignancy
proven. She was referred to acute Oncology and
Palliative care.

It was interesting to note here that our both patients
developed pulmonary embolism as well. It has been
suggested in few studies that patients with suspected
cancer-associated hypercoagulability should also be
screened for other thromboembolic complications
especially deep vein thrombosis which it is of
therapeutic significance4.Our second patient had a DVT
prior to having stroke. Also interesting was to note was
the fact that our second patient developed first stroke
while she was on oral anticoagulant Rivaroxaban and
again developed extensive DVT of leg while on
therapeutic doses of Dalteparin(LMVH) suggesting a
severe hypercoagulable state.

DISCUSSION
Both the patients were interesting because of the fact
that they first presented with stroke and were later on
found to be having a malignancy. Stroke as a first
presentation of malignancy is a rare phenomenon1.
There are many ways in which stroke occurs in cancer
as mentioned in different studies. Coagulopathic
conditions
involve
disseminated
intravascular
coagulation,
thrombocytopenia,
nonbacterial
thrombotic endocarditis, and cerebral intravascular
coagulation2.

Therefore, we suggest that in patients with stroke in
which the usual workup is negative, before labelling
them as cryptogenic stroke, workup/ screening for
hidden malignancy should be undertaken. This holds
particularly true if if there is suspicion of hypercoaguble
state, especially if D dimers are very high, if there is
evidence of DVT/PE, stroke has affected multiple
arterial territories, thrombophilia screen is negative and
there is evidence of anaemia and inflammatory markers
are raised. Ultrasound abdomen was particularly
rewarding in this regard. Our both patients were
diagnosed on ultrasound abdomen.

Complications of chemotherapy, radiation therapy,
direct tumor effects include intratumoral hemorrhage,
arterial and venous sinus invasion by tumor mass or
leptomeningeal infiltrates, and tumor emboli, all can
occur2.
Finally, septic infarction from fungal or bacterial sepsis
and infectious vasculitis can manifest in cancer
patients immunocompromised by malignancy or cancer
therapy2.
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